Shellback Capital’s Teladoc Health TDOC Stock Holding History

Shellback Capital’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-154,583	Closed	-$10.3M	–	91
2019 Q2	$10.3M	Buy	+154,583	New	+$9.01M	1.28%	26

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Shellback Capital's TDOC Position: Q3 2019 in Review

Shellback Capital sold out of Teladoc Health (TDOC) in Q3 2019, closing a stake of 154,583 shares — an estimated $10.3M sold.

Shellback Capital first reported a position in TDOC in Q2 2019 and held it in 1 quarter. The position peaked at $10.3M in Q2 2019. 378 funds tracked by Wall St. Rank hold TDOC as of Q3 2019.

Shellback Capital reported no remaining Teladoc Health position as of Q3 2019 after selling out during the quarter.
Shellback Capital sold 154,583 Teladoc Health shares in Q3 2019, an estimated $10.3M.
Shellback Capital first reported a position in Teladoc Health in Q2 2019 and held it in 1 quarter.
Shellback Capital's Teladoc Health position peaked at $10.3M in Q2 2019.
378 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2019.

Based on Shellback Capital's 13F filing for Q3 2019, filed 14 Nov 2019.